Early Phase 1 Renal Cell Carcinoma Clinical Trials
6 recruitingEarly Phase 1
What is a Early Phase 1 trial?
Early Phase 1 trials are the earliest stage of testing in humans. These small studies focus on how a drug is processed in the body and how it affects the body, often enrolling just a handful of participants to establish initial safety data.
Showing 1–6 of 6 trials
Recruiting
Early Phase 1
Memory-like Natural Killer (NK) Cell Therapy in Patients With Renal Cell Carcinoma or Urothelial Carcinoma
Urothelial CarcinomaRenal Cell CarcinomaChromophobe Renal Cell Carcinoma+2 more
Dana-Farber Cancer Institute10 enrolled2 locationsNCT06318871
Recruiting
Early Phase 1
Clinical Evaluation of [68Ga]Ga-XT771 PET for Diagnosis in Patients With Glioblastoma and Clear Cell Renal Cell Carcinoma
Clear Cell Renal Cell Carcinoma and Glioblastoma
Chinese PLA General Hospital15 enrolled1 locationNCT07067905
Recruiting
Early Phase 1
Neoadjuvant Pembrolizumab and Lenvatinib for Renal Cell Carcinoma
Renal Cell Carcinoma
Abramson Cancer Center at Penn Medicine30 enrolled1 locationNCT05733715
Recruiting
Early Phase 1
Rapid Sequencing of Approved Therapies in Patients with Metastatic or Unresectable Clear Cell Renal Cell Carcinoma
Renal Cell Carcinoma
Icahn School of Medicine at Mount Sinai20 enrolled1 locationNCT05188118
Recruiting
Early Phase 1
Anti-CD70-CAR-T Cell Injection for the Treatment of Locally Advanced or Relapsed/Metastatic CD70+ Inoperable Renal Cells
Renal Cell Carcinoma
Shanghai Changzheng Hospital9 enrolled1 locationNCT06586658
Recruiting
Early Phase 1
[18F] PSMA-1007 PET/CT in Metastatic Clear Cell Renal Cell Carcinoma
Metastatic Clear Cell Renal Cell Carcinoma
Western University30 enrolled1 locationNCT06428708